NewGenIvf Group Ltd (NIVF): Total Liabilities
$6.74M
As of 2025-12-31
+33.9%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.74M | +33.1% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $5.06M | +307.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $1.24M | -55.7% | 2025-05-15, Balance as of period end |
| 2022-12-31 | $2.80M | n/a | 2024-08-20, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| NewGenIvf Group Ltd (NIVF) | 2025-12-31 | $6.74M | +33.1% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $80.33M | +3.1% |
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $890.6K | -37.5% |
| Pacific Health Care Organization Inc (PFHO) | 2024-12-31 | $745.6K | -21.4% |
| Marpai, Inc. (MRAI) | 2025-12-31 | $43.47M | +7.1% |
| Charming Medical Ltd (MCTA) | 2026-03-31 | $4.69M | -11.7% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $55.63M | +27.1% |
| BioRestorative Therapies, Inc. (BRTX) | 2024-12-31 | $3.75M | +43.8% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $226.39M | +22.3% |
Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗